Financial results submitted for period ended September 30, 2026
INFLUX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Minute windows have no benchmark: there is no intraday index history to compare against.
Influx Healthtech Limited submitted financial results for the period ended September 30, 2026 to NSE. The filing extract includes no consolidated or standalone figures, so quarterly revenue, profit, margin, cash flow and balance-sheet signals cannot be confirmed.
The filing provides no financial detail, so the effect on earnings, cash flow, leverage and shareholder sentiment cannot be assessed.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹85.41 Cr | ₹66.76 Cr | +27.9% |
| Operating profit | ₹15.88 Cr | ₹12.98 Cr | +22.3% |
| Profit after tax | — | — | — |
| EBITDA margin | — | — | — |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.